Meeting News
August 16, 2018
CHICAGO — Pembrolizumab demonstrated “promising” antitumor activity among patients with advanced small-cell lung cancer…
Meeting News
August 15, 2018
CHICAGO — The use of a lymph node specimen collection kit during non-small cell lung cancer resection significantly improved staging quality…
Meeting News
August 14, 2018
CHICAGO — Pembrolizumab failed to demonstrate efficacy in patients with PD-L1-positive, EGFR-mutated advanced non-small cell lung cancer who…
Meeting News
August 13, 2018
CHICAGO — Phase 3 data from the NEJ026 trial showed that a combination regimen of bevacizumab plus erlotinib prolonged PFS compared with…
Meeting NewsVideo
August 7, 2018
CHICAGO — Docetaxel in combination with the novel agent B-701 appeared safe and effective in patients with locally advanced or metastatic…
Meeting News
August 7, 2018
CHICAGO — Researchers have identified relapse patterns of nonclear cell renal cell carcinomas — an understudied group of rare kidney…
Meeting NewsVideo
August 6, 2018
CHICAGO — Erdafitinib induced a robust response among patients with chemotherapy-refractory metastatic or unresectable urothelial carcinoma and…
Meeting News
August 6, 2018
CHICAGO — Phase 2 data from the ABACUS trial showed that neoadjuvant atezolizumab therapy was safe and demonstrated a “meaningful”…
Meeting News
August 4, 2018
CHICAGO — The addition of cytoreductive nephrectomy to treatment with sunitinib malate did not provide a survival benefit for intermediate and…
Meeting News
August 3, 2018
CHICAGO — Updated phase 3 data from the ARCHER 1050 trial showed that dacomitinib improved OS compared with gefitinib among patients with newly…